McKesson Corp (MCK)

165.92
0.85 0.51
NYSE : Services
Prev Close 165.07
Open 165.48
Day Low/High 164.62 / 166.18
52 Wk Low/High 114.53 / 197.91
Volume 1.22M
Avg Volume 1.69M
Exchange NYSE
Shares Outstanding 211.46M
Market Cap 34.91B
EPS 22.90
P/E Ratio 7.09
Div & Yield 1.12 (0.70%)

Latest News

Investors Should Ignore Washington: Cramer's 'Mad Money' Recap (Tuesday 7/18/17)

Investors Should Ignore Washington: Cramer's 'Mad Money' Recap (Tuesday 7/18/17)

Investors need to focus on earnings and not be distracted by the circus in Washington, Jim Cramer says.

McKesson Corporation Fiscal 2018 First Quarter Conference Call Scheduled For July 27, 2017

McKesson Corporation Fiscal 2018 First Quarter Conference Call Scheduled For July 27, 2017

McKesson Corporation (NYSE:MCK) will release financial results for its first fiscal quarter ended June 30, 2017 on Thursday, July 27, 2017, prior to the opening of trading on the New York Stock Exchange.

Bristol Myers Vies to Be King of Immune-Boosting Cancer Drugs with New Trial Update

Bristol Myers Vies to Be King of Immune-Boosting Cancer Drugs with New Trial Update

The trial's success props open doors for exploring new uses for Opdivo's treatment in immunotherapy.

Celgene Enters PD1 Market with BeiGene Deal

Celgene Enters PD1 Market with BeiGene Deal

Celgene acquired the rights to BeiGene's PD-1 checkpoint inhibitor, propelling the biotech giant forward in immuno-oncology research.

McKesson Reaffirms Fiscal 2018 Guidance

McKesson Corporation (NYSE:MCK) today reaffirmed its earnings guidance for the fiscal year ending March 31, 2018 and the underlying key assumptions provided in its press release on May 18, 2017.

McKesson Corporation To Webcast Investor Day

McKesson Corporation (NYSE:MCK) will host an Investor Day in Boston on Wednesday, June 28, 2017, including presentations by John Hammergren, chairman, president and chief executive officer; James Beer, executive vice...

Dems Roast Trump for Leaving Medicare Out of Drug Price Order

Dems Roast Trump for Leaving Medicare Out of Drug Price Order

The main thrust of the order appears to be easing regulatory hurdles to drug approvals, which could lower the cost of bringing new treatments to market and thus lower prices.

Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space

Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space

Generic drugmakers are likely to limit themselves to acquisitions of small- and mid-sized companies in the immediate future because of over-leveraging and turmoil in the executive ranks..

Short Interest Declines 18% For MCK

The most recent short interest data has been released for the 05/31/2017 settlement date, which shows a 874,390 share decrease in total short interest for McKesson Corp , to 3,950,969, a decrease of 18.12% since 05/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Cramer: You Need 2 Monday Morning Game Plans

Cramer: You Need 2 Monday Morning Game Plans

We really want to shake out the weak hands here.

The Fortune 500 Rakes in More Than $12 Trillion In Sales, and It's Led by Retail Giant Walmart

The Fortune 500 Rakes in More Than $12 Trillion In Sales, and It's Led by Retail Giant Walmart

Walmart retains the top spot for the fifth straight year with 2016 revenues totaling $485.9 billion.

Analysts' Actions -- Ambarella, BlackBerry, PVH Corp., Zynga and More

Analysts' Actions -- Ambarella, BlackBerry, PVH Corp., Zynga and More

Here are Tuesday's top research calls, including downgrades for Ambarella and BlackBerry, and upgrades for PVH Corp. and Zynga.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: MCK, MRVL, NSH, TEF Downgrades: ANW, BOSC, FET, GPX, MIXT, UAN Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

McKesson Corporation To Present At The Goldman Sachs 38th Annual Global Healthcare Conference

McKesson Corporation (NYSE:MCK) today announced that James Beer, executive vice president and chief financial officer, will present at the Goldman Sachs 38 th Annual Global Healthcare Conference in Rancho Palos Verdes at...

McKesson Declares Quarterly Dividend May 24, 2017

The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of twenty-eight cents per share on Common Stock.

McKesson Upgraded at JPMorgan

McKesson Upgraded at JPMorgan

The firm's analyst believes additional value should be unlocked from the Change transaction and that the valuation discount versus peers is unwarranted.

Analysts' Actions -- Cloudera, Carvana, Domino's, McKesson and More

Analysts' Actions -- Cloudera, Carvana, Domino's, McKesson and More

Here are Tuesday's top research calls, including new coverage of recent IPOs Cloudera and Carvana, as well as new analyst coverage of Domino's Pizza and an upgrade of McKesson.

These Stocks Are Changing Direction

These Stocks Are Changing Direction

Finding bullish and bearish reversals in the market.

Bulls Won the Day: Cramer's 'Mad Money' Recap (Friday 5/19/17)

Bulls Won the Day: Cramer's 'Mad Money' Recap (Friday 5/19/17)

Ahead of Fed's June meeting, investors will need to start paying close attention to Fed officials and economic data.

Rebound Reality; Best Tech Story: Jim Cramer's Best Blog

Rebound Reality; Best Tech Story: Jim Cramer's Best Blog

Jim Cramer discusses the rebound and also mentions the best tech story that no one knows about.

Cramer: The Rebound is Real. Now What?

Cramer: The Rebound is Real. Now What?

With stocks rebounding, investors face a tough choice.

McKesson Shares Jump After Fourth Quarter Beat

McKesson Shares Jump After Fourth Quarter Beat

The drug distributor reported better-than-expected adjusted EPS for the fourth quarter of fiscal 2017.

McKesson Reports Fiscal 2017 Fourth-Quarter And Full-Year Results

McKesson Corporation (NYSE:MCK) today reported that revenues for the fourth quarter ended March 31, 2017, were $48.

Market Recon: Corporate America Is Fundamentally Sound

Market Recon: Corporate America Is Fundamentally Sound

Of firms that reported, 75% beat expectations for earnings per share, while 64% beat revenue projections.

Eyes Are on McKesson's Guidance

Eyes Are on McKesson's Guidance

The drug distributor is scheduled to report quarterly results after the market close on Thursday.